News

The effect state laws have on the number of healthcare-acquired infections (HAIs) is addressed in a new report from the National Conference of State Legislatures (NCSL).

Virgo Publishing, LLC, an integrated business-to-business information services company whose titles include Infection Control Today magazine, announces the appointment of John Siefert as chief executive officer.

Researchers found that influenza A H1N1 caused substantial morbidity in recipients of solid-organ transplants during the 2009-2010 pandemic.

Determining the source of an infectious outbreak can be difficult in and of itself, but a moving reservoir adds to the challenges. That's what researchers encountered when investigating cases of Legionnaires' disease that kept presenting in one city in Spain.

The Cardinal Health Foundation today announced that, for the third consecutive year, it has awarded more than $1 million in grant funding to help U.S. hospitals, health systems and community health clinics improve the efficiency and quality of care.

In a new study of four adenovirus vectors, researchers from the Wistar Institute show that a reportedly rare human adenovirus, called AdHu26, is not so rare, after all, and would thus be unlikely to be optimal as a vaccine carrier for mass vaccination.

Two researchers from the CDC report on the emerging issue of Clostridium difficile transmission via food in the community setting.  

The Association for the Advancement of Medical Instrumentation (AAMI) announces that the Industrial Ethylene Oxide Sterilization for Medical Devices Workshop, a three-day, highly interactive advanced workshop, will be held October 4-6, 2010 at the Westin Peachtree Plaza in Atlanta.

After more than a decade of development at the National Institutes of Health, a vaccine to prevent infection by the mosquito-borne dengue virus has begun human clinical testing.

A new study by researchers from UCLA and Harvard University has found disparities among children suffering from repeated ear infections.

On Aug. 5, 2010, CDC's Advisory Committee on Immunization Practices (ACIP) met to discuss recommendations for use in the United States of seasonal influenza trivalent inactivated vaccine (TIV) [Afluria] manufactured by CSL Limited during 2010-11.